Search results
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 5 days agoFull-Year Guidance: Adjusted EPS guidance raised to $2.15 to $2.35, reaffirms revenue guidance of...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 2 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Pfizer (NYSE:PFE) Earns Outperform Rating from BMO Capital Markets
ETF DAILY NEWS· 1 day agoBMO Capital Markets reaffirmed their outperform rating on shares of Pfizer (NYSE:PFE – Free Report) in a report issued on Thursday, Benzinga reports. BMO Capital Markets currently ...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 1 day agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, Benzinga reports. They ...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 2 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 2 weeks agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 2 weeks agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 4 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 2 weeks agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...